MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hool, L. C.
Right arrow Articles by Harvey, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hool, L. C.
Right arrow Articles by Harvey, R. D.

0026-895X/97/050853-08$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:853-860 (1997).

Role of G Proteins in alpha 1-Adrenergic Inhibition of the beta -Adrenergically Activated Chloride Current in Cardiac Myocytes

Livia C. Hool, Lisa M. Oleksa, and Robert D. Harvey

Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio, 44106.

alpha 1-Adrenergic receptor stimulation can inhibit the Cl- current activated by beta -adrenergic receptor agonists in guinea-pig ventricular myocytes. We investigated the role of G proteins in mediating this type of alpha -adrenergic response. The combined alpha - and beta -adrenergic agonist norepinephrine (NE) activated the Cl- current with an EC50 value of 53 nM. Preincubation of myocytes with PTX decreased the EC50 value for NE activation of the Cl- current to 5.9 nM, and addition of the alpha 1-adrenergic receptor antagonist prazosin did not cause any further change in sensitivity to NE. These results suggest that the alpha 1-adrenergic inhibition of beta -adrenergic responses is mediated through a PTX-sensitive G protein. However, PTX pretreatment also increased the sensitivity of the Cl- current to the selective beta -adrenergic agonist isoproterenol (Iso), which indicates that the PTX treatment increases the sensitivity to beta -adrenergic stimulation alone and that this could account for the PTX-induced change in sensitivity to NE. Consistent with this idea, the selective alpha 1-adrenergic receptor agonist methoxamine was still able to inhibit the Cl- current activated by Iso in PTX-treated myocytes. However, the sensitivity to methoxamine was significantly decreased. In control cells, the Cl- current activated by 30 nM Iso was inhibited by methoxamine with an EC50 value of 8.3 µM, but in PTX-treated cells, the EC50 value was 284 µM. The EC50 for methoxamine inhibition was similarly increased when the Cl- current was activated by 300 nM Iso. These data suggest that the effects of PTX on alpha 1-adrenergic responses can actually be explained by changes in the sensitivity to beta -adrenergic stimulation. To verify the role for a G protein in mediating the inhibitory alpha 1-adrenergic response, we examined the effect of methoxamine on the Cl- current activated in cells dialyzed with the nonhydrolyzable GTP analogue guanosine-5'-O-(3-thio)triphosphate. Pre-exposure to methoxamine resulted in an attenuated response upon subsequent exposure to Iso alone. We conclude that alpha 1-adrenergic inhibition of beta -adrenergic responses is mediated by a G protein-dependent mechanism that appears to be PTX-insensitive.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Physiol.Home page
S. Yamamoto-Mizuma, G.-X. Wang, and J. R. Hume
P2Y purinergic receptor regulation of CFTR chloride channels in mouse cardiac myocytes
J. Physiol., May 1, 2004; 556(3): 727 - 737.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz
Anion Transport in Heart
Physiol Rev, January 1, 2000; 80(1): 31 - 81.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Sorota
Insights into the structure, distribution and function of the cardiac chloride channels
Cardiovasc Res, May 1, 1999; 42(2): 361 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Hool and R. D. Harvey
Role of beta 1- and beta 2-adrenergic receptors in regulation of Cl- and Ca2+ channels in guinea pig ventricular myocytes
Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1669 - H1676.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics